Both in Pharmaceuticals
Bristol-Myers Squibb vs ABBVIE
Over the past year BMY returned +35.6% and ABBV returned +35.2%; their daily moves had a correlation of 0.49.
BMY +35.6% ABBV +35.2%Growth of $1, one year, split-adjusted
| Metric | BMY | ABBV |
|---|---|---|
| Price | $62.48 | $294.89 |
| Market cap | $127.71B | $521.11B |
| Today | +1.78% | +1.41% |
| 1 month | +1.7% | +13.4% |
| 6 months | +7.3% | +42.7% |
| Year to date | +15.8% | +29.1% |
| 1 year | +46.7% | +31.0% |
| Revenue growth (YoY) | +5.7% | +10.2% |
| Gross margin | 71.3% | 74.7% |
| Net margin | 25.6% | 21.3% |
| P/E (TTM) | 13.8× | 82.8× |
| Price / sales | 2.6× | 8.1× |
| Net cash | -$32.05B | -$64.25B |
| Dividend yield | 4.03% | 2.35% |
| Volatility (60d) | 27.3% | 19.6% |
| Short % of float | 2.4% | 0.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).